Skip to content

Abstract 6852: Monogenic and Polygenic Risk Enrichment in Thoracic Aortic Aneurysm and Dissection Across Ancestries

Nov 2026 · Circulation · 0 citations

Abstract

Background: Thoracic aortic aneurysm and dissection (TAAD) is a devastating condition with high heritability and substantial morbidity and mortality. Current ACC/AHA guidelines recommend surveillance imaging for first-degree relatives of affected individuals, who carry 4 to 5-fold greater risk of TAAD. However, most TAAD patients lack a known affected relative and clinical genetic evaluation - relying predominantly on monogenic testing - identifies pathogenic variants in only a small fraction of cases. Whether polygenic susceptibility, which has emerged as a determinant of TAAD risk, could broaden the screening framework remains undefined. Methods: Among 414,830 participants of the All of Us Research Program with whole genome sequencing (WGS), TAAD cases were identified and matched 1:4 to controls by age and sex. Pathogenic or likely pathogenic (P/LP) variants in 17 high-confidence aortopathy genes were identified from ClinVar-annotated WGS. An 89-variant ascending aortic diameter polygenic risk score (PRS; PGS Catalogue #PGS002267) was applied to all participants. Firth’s bias-reduced and standard logistic regression models were used to estimate the associations of P/LP carrier status and PRS with TAAD, respectively, adjusting for age, sex, and five genetic principal components and stratifying by genomically inferred ancestry (European [EUR] and African [AFR]). Results: A total of 3,083 participants with TAAD and 12,332 matched controls were identified. P/LP variants in aortopathy genes were identified in 0.88% of EUR cases versus 0.07% of EUR controls (OR: 11.08; 95% CI: 4.88-28.98; p<0.001), with FBN1 most commonly implicated. Among AFR participants, P/LP carrier prevalence was comparable among cases (0.84%) and the association with TAAD was significant (OR: 6.61; 95% CI: 1.27-40.19; p=0.026) (Figure 1). The aortic diameter PRS demonstrated a monotonic dose-response with TAAD in EUR participants (OR per SD increase: 1.47; 95% CI: 1.40-1.54; p<0.001), with individuals in the top PRS decile carrying 4-fold greater odds than those in the lowest decile (OR: 4.31; 95% CI: 3.41-5.44; p<0.001). The PRS was also associated with TAAD among AFR participants, with attenuated effects relative to EUR participants (OR per-SD: 1.24; p<0.001; top vs bottom decile OR: 2.54; p<0.001) (Figure 2). Conclusion: P/LP variants in established aortopathy genes conferred markedly elevated individual risk of TAAD but were present in fewer than 1% of cases. A PRS identified a substantially larger at-risk population, with risk estimates approaching the magnitude used to justify current family-based surveillance recommendations, potentially enabling proactive risk identification before a sentinel familial event. These findings motivate continued genetic discovery and the development of multi-ancestry PRS to support equitable implementation of genetic risk stratification for aortic disease.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.